The Future of Cancer Care
Name:
The Future of Cancer Care
Date:
November 14, 2019
Time:
8:00 AM - 10:00 AM EST
Website:
Fight Cancer CT Forum
Event Description:
American Cancer Society's 4th Annual Policy Forum -- The Future of Cancer Care: The Role of Biomarkers in Advancing Personalized Medicine
This event will examine the current impact and future potential of biomarkers in cancer research, diagnosis and treatment and discuss advancements and barriers to new technological discoveries. Participants will include key stakeholders throughout the oncology community, including leaders in life sciences, health care systems, academia, provider groups, patient advocacy, public policy, business, and others.
Presenters Include:
Pratheesh Sathyan, Ph.D. - National Lead Medical Science Liaison, Foundation Medicine
Barbara Moehring - Director of Clinical Development and Medical Affairs Oncology at Boehringer Ingelheim
Jairaj A. Puthenveettil, Ph.D., M.B.A- Associate Director, Oncology Health Systems Bristol-Myers Squibb
Daniel P. Petrylak, MD - Professor of Medicine (Medical Oncology) and of Urology; Co-Leader, Cancer Signaling Networks, Yale Cancer Center
Alpesh J. Amin, M.D. - Medical Director US Oncology Medical, Novartis
State Representative Dr. William Petit, House Ranking Member of the Public Health Committee will moderate the program.
This event will examine the current impact and future potential of biomarkers in cancer research, diagnosis and treatment and discuss advancements and barriers to new technological discoveries. Participants will include key stakeholders throughout the oncology community, including leaders in life sciences, health care systems, academia, provider groups, patient advocacy, public policy, business, and others.
Presenters Include:
Pratheesh Sathyan, Ph.D. - National Lead Medical Science Liaison, Foundation Medicine
Barbara Moehring - Director of Clinical Development and Medical Affairs Oncology at Boehringer Ingelheim
Jairaj A. Puthenveettil, Ph.D., M.B.A- Associate Director, Oncology Health Systems Bristol-Myers Squibb
Daniel P. Petrylak, MD - Professor of Medicine (Medical Oncology) and of Urology; Co-Leader, Cancer Signaling Networks, Yale Cancer Center
Alpesh J. Amin, M.D. - Medical Director US Oncology Medical, Novartis
State Representative Dr. William Petit, House Ranking Member of the Public Health Committee will moderate the program.
